Month: March 2024

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Archive

2024.03.26

Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project – Company will raise capital from founding shareholders and investors

Genomtec will raise PLN 10.6 million (equivalent to over USD 2.6 million), most of which will be used to fund the research & development of ...
Read
2024.03.12

Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Genomtec S.A.,  announces that the Extraordinary General Meeting of Shareholders of the company has appointed two new members to the Supervisory ...
Read

Archive